Here are relevant reports on : cardiology-market
-
Interventional Cardiology Devices Market by Type [Stents (Drug-eluting Stent, Bare Metal Stent), Catheters (Angiography, Guiding, IVUS/OCT Catheter), Balloons, Plaque Modification Devices, Hemodynamic Flow Alteration], End User-Global Forecast to 2031
The global interventional cardiology devices market, valued at USD 29.41 billion in 2025, stood at USD 31.12 billion in 2026 and is projected to advance at a resilient CAGR of 6.4% from 2026 to 2031, culminating in a forecasted valuation of USD 42.39 billion by the end of the period. The growing preference for minimally invasive catheter-based procedures over conventional open-heart surgeries is further boosting the market, owing to advantages such as shorter hospital stays, faster recovery, and lower procedural risk.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027
The global bioanalytical testing services market growth is primed to transition from $2.9 billion in 2022 to $6.0 billion by 2027, showcasing a strong CAGR of 15.6%. The major factors influencing the growth of the market include the well-established pharmaceutical industry, the strong presence of major service providers, the large number of ongoing clinical trial studies, high R&D expenditure, growth in the biosimilars and generics markets, and the rise in the outsourcing of preclinical, clinical, and laboratory testing services by pharmaceutical and biopharmaceutical companies in the region.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Cardiovascular Information System Market by System Type (CVIS, Cardiology PACS), Components (Software, Services), Mode of Operation (Web-based, Onsite), End User, Applications (Catheterization, ECG, Holter, ICD, Electrocardiography) - Forecasts to 2020
The global cardiovascular information systems market is expected to reach USD 917.2 Million by 2020 from USD 621.4 Million in 2015, at a CAGR of 8.1%. On the basis of type, the cardiovascular information systems market is segmented into CVIS and C-PACS. The CVIS segment is projected to grow at the highest CAGR from 2015 to 2020, owing to the increasing incidence and prevalence of cardiovascular diseases.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
Medical Connectors Market by Product (Radiofrequency, Push-Pull, Optical, Non-magnetic), Application (Patient Monitoring, Cardiology, Neurology, Diagnostic Imaging, Respiratory, Dental), End User (Hospitals, Clinics) & Region - Global Forecast to 2030
The global medical connectors market, valued at US$1.64 billion in 2024, stood at US$1.74 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$ 2.45 billion by the end of the period. The growth of the Asia Pacific medical connectors market is strongly supported by the rapid expansion of healthcare infrastructure and an increased adoption of advanced medical technologies across developing nations.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Radiation Dose Management Market by Offering (Product: Integrated, Standalone; Services), Modality (CT, Mammography, NM), Revenue Model (Pay-Per Procedure, Annual Purchase), Application (Oncology, Cardiology, Ortho), End User & Region - Global Forecast to 2028
The global radiation dose management market, valued at US$293 million in 2022, stood at US$343 million in 2023 and is projected to advance at a resilient CAGR of 13.8% from 2023 to 2028, culminating in a forecasted valuation of US$654 million by the end of the period. The growth of this market can be attributed to the increasing use of medical imaging modalities due to rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in installation base of radiology equipment, and growing awareness about radiation dose management
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Latin America Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable, Cart-based), Technology (Digital, Contrast), Animal Type (Small, Large), Application (Obstetrics, Cardiology, Orthopedic), End User (Hospitals) - Forecast to 2031
The Latin America Veterinary Ultrasound Market, valued at USD 0.030 billion in 2025, stood at USD 0.033 billion in 2026 and is projected to advance at a resilient CAGR of 8.1% from 2026 to 2031, culminating in a forecasted valuation of USD 0.048 billion by the end of the period. The other growth factors include an increase in investments in veterinary healthcare infrastructure, a growing number of specialty animal hospitals and clinics, and greater access to portable and affordable ultrasound systems.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
The Asia Pacific in vitro diagnostics market is valued at an estimated USD 29.27 billion in 2026 and is projected to reach USD 45.11 billion by 2031 at a CAGR of 9.0% during the forecast period. The Key Players F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Danaher (US), Sysmex Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., (China)., Siemens Healthineers AG (Germany), bioMérieux (France), Illumina, Inc. (US), Becton, Dickinson and Company (US), and QuidelOrtho Corporation (US).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Immunochemistry Instruments & Reagents Market by Product [Analyzer (CLIA, IFA, ELA, RIA, & ELFA), Stainer, Incubator, Autoclave, Consumables (Antibodies, Enzymes, & Antigens)], Cardiology, Endocrinology, Oncology, Hospitals, & Labs –Forecast to 2019
The global immunochemistry instruments and reagents market is expected to reach $24.5 billion by 2019 from $17.3 billion in 2014, growing at a CAGR of 7.2% from 2014 to 2019. There is a rising focus on biomarker development across the globe as they help in detection of various diseases in their initial stage. Immunochemistry plays a crucial role in the development of biomarkers thus with the growing demand of biomarkers, the market for immunochemistry instruments and reagents will also flourish. Furthermore, government support in terms of funds and grants has also provided much needed impetus to this market. Moreover, increasing focus on drug monitoring and growing incidences of various diseases are other factors driving the growth of the market. In addition to this, technological advancements due to which automated and more accurate instruments are present in the market is another major factor propelling the growth of the market. However, factors such as stringent regulations for the development and launch of immunochemistry products and low adoption rate of automated immunochemistry products in developing economies due to high cost can hinder the growth of the market in coming years.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Diagnostic Catheter Market by Type (Angiography, OCT, Ultrasound, Electrophysiology, Pressure and Hemodynamic Monitoring), Application Area (Cardiology, Urology, Neurology, Gastroenterology), End User (Hospitals, Imaging Centers) - Global Forecast to 2021
The global diagnostic catheters market is projected to grow at a CAGR of around 7.3%. The diagnostic catheters market comprises a network of players involved in the research and product development; raw material supply; medical device manufacturing; distribution and sale; and post-sales services. The major players in the global market are Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic plc. (Ireland), Johnson & Johnson (U.S.), Koninklijke Philips N.V. (The Netherlands), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), C. R. Bard, Inc. (U.S.), Edward Lifesciences Corporation (U.S.), and Terumo Corporation (Japan).
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Inflation Device Market by Display Type (Analog & Digital), Capacity (20ml, 30ml, 60ml), Application (Interventional Cardiology, Radiology, Peripheral Vascular, Urology), End User (Hospitals & Clinics, Ambulatory Surgery Centers) - Forecasts to 2024
The inflation device market is projected to reach USD 600 Million by 2024, at a CAGR of 4.7%. The rising adoption of minimally invasive procedures, the presence of developed healthcare infrastructure in a majority of developed countries, the growing incidence of CVD, and the less-stringent approval procedures are contributing to the growth of the market. With the growth of the geriatric population, the prevalence of coronary artery disease is also expected to increase, which is a major target indication for interventional cardiology procedures that utilizes inflation devices to inflate and deflate the balloon. Aforementioned key factors are likely to fuel growth of inflation devices market over the forecast period. The major players operating in the inflation devices market are Merit Medical Systems (US), Boston Scientific Corporation (US), Cardinal Health (US), CONMED Corporation (US), Medtronic plc (Ireland), Acclarent Inc. (US), Cook Medical (US), Atrion Corporation (US), Becton, Dickinson and Company (US), Terumo Medical Corporation (Japan), B. Braun Melsungen AG (US), Olympus Corporation (Japan), Teleflex Incorporated (US), and US Endovascular (US), among others.
- Published: April 2019
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
